Marcus J. Calkins, Ph.D.
Affiliations: | University of Wisconsin, Madison, Madison, WI |
Area:
visual working memory, attention, dynamical systems approaches to cognitionGoogle:
"Marcus Calkins"Mean distance: 15.94 (cluster 15) | S | N | B | C | P |
Parents
Sign in to add mentor| Jeffrey S. Johnson | grad student | 2008 | UW Madison | |
| (Induction of the Nrf2/ARE signaling pathway can protect against striatal neurotoxicity.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Hung KM, Chen PC, Hsieh HC, et al. (2016) Mitochondrial defects arise from nucleoside/nucleotide reverse transcriptase inhibitors in neurons: Potential contribution to HIV-associated neurocognitive disorders. Biochimica Et Biophysica Acta |
| Hung KM, Calkins MJ. (2016) Mitochondrial homeostatic disruptions are sensitive indicators of mitochondrial stress in neurons with defective mitochondrial DNA transactions. Mitochondrion |
| Fu MH, Li CL, Lin HL, et al. (2015) Stem cell transplantation therapy in Parkinson's disease. Springerplus. 4: 597 |
| Lin CH, Li HY, Lee YC, et al. (2015) Landscape of Pin1 in the cell cycle. Experimental Biology and Medicine (Maywood, N.J.). 240: 403-8 |
| Calkins MJ, Manczak M, Reddy PH. (2012) Mitochondria-Targeted Antioxidant SS31 Prevents Amyloid Beta-Induced Mitochondrial Abnormalities and Synaptic Degeneration in Alzheimer's Disease. Pharmaceuticals (Basel, Switzerland). 5: 1103-19 |
| Calkins MJ, Townsend JA, Johnson DA, et al. (2010) Cystamine protects from 3-nitropropionic acid lesioning via induction of nf-e2 related factor 2 mediated transcription. Experimental Neurology. 224: 307-17 |
| Calkins MJ, Vargas MR, Johnson DA, et al. (2010) Astrocyte-specific overexpression of Nrf2 protects striatal neurons from mitochondrial complex II inhibition. Toxicological Sciences : An Official Journal of the Society of Toxicology. 115: 557-68 |
| Calkins MJ, Johnson DA, Townsend JA, et al. (2009) The Nrf2/ARE pathway as a potential therapeutic target in neurodegenerative disease. Antioxidants & Redox Signaling. 11: 497-508 |
| Johnson JA, Johnson DA, Kraft AD, et al. (2008) The Nrf2-ARE pathway: an indicator and modulator of oxidative stress in neurodegeneration. Annals of the New York Academy of Sciences. 1147: 61-9 |
| Li J, Calkins MJ, Johnson DA, et al. (2007) Role of Nrf2-dependent ARE-driven antioxidant pathway in neuroprotection. Methods in Molecular Biology (Clifton, N.J.). 399: 67-78 |